These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial magnetic nanoparticles based-therapies for controlling infectious diseases. Rodrigues GR; López-Abarrategui C; de la Serna Gómez I; Dias SC; Otero-González AJ; Franco OL Int J Pharm; 2019 Jan; 555():356-367. PubMed ID: 30453018 [TBL] [Abstract][Full Text] [Related]
6. Drug delivery system based on chronobiology--A review. Mandal AS; Biswas N; Karim KM; Guha A; Chatterjee S; Behera M; Kuotsu K J Control Release; 2010 Nov; 147(3):314-25. PubMed ID: 20691738 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial hydrogels: a new weapon in the arsenal against multidrug-resistant infections. Ng VW; Chan JM; Sardon H; Ono RJ; García JM; Yang YY; Hedrick JL Adv Drug Deliv Rev; 2014 Nov; 78():46-62. PubMed ID: 25450263 [TBL] [Abstract][Full Text] [Related]
9. Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors. Willers C; Wentzel JF; du Plessis LH; Gouws C; Hamman JH Expert Opin Ther Targets; 2017 Jan; 21(1):23-36. PubMed ID: 27892739 [TBL] [Abstract][Full Text] [Related]
10. Ask the experts: transdermal drug delivery. Ther Deliv; 2013 Oct; 4(10):1235-8. PubMed ID: 24116908 [TBL] [Abstract][Full Text] [Related]
11. Drug delivery global summit--evaluating emerging technologies. Mustata G; Dinh SM Expert Opin Drug Deliv; 2005 Jan; 2(1):185-7. PubMed ID: 16296744 [TBL] [Abstract][Full Text] [Related]
12. Anti-infectives in the 21st century. Clough J Drug Discov Today; 2002 Oct; 7(20):1036-8. PubMed ID: 12546891 [No Abstract] [Full Text] [Related]
13. Vaccine presentations and delivery technologies--what does the future hold? Clements CJ; Wesselingh SL Expert Rev Vaccines; 2005 Jun; 4(3):281-7. PubMed ID: 16026244 [TBL] [Abstract][Full Text] [Related]
14. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Hearnden V; Sankar V; Hull K; Juras DV; Greenberg M; Kerr AR; Lockhart PB; Patton LL; Porter S; Thornhill MH Adv Drug Deliv Rev; 2012 Jan; 64(1):16-28. PubMed ID: 21371513 [TBL] [Abstract][Full Text] [Related]
15. Strategies for antimicrobial drug delivery to biofilm. Martin C; Low WL; Gupta A; Amin MC; Radecka I; Britland ST; Raj P; Kenward KM Curr Pharm Des; 2015; 21(1):43-66. PubMed ID: 25189862 [TBL] [Abstract][Full Text] [Related]
16. Recent trends in oral drug delivery: a review. Gupta H; Bhandari D; Sharma A Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):162-73. PubMed ID: 19519576 [TBL] [Abstract][Full Text] [Related]
17. Enhanced composite electrospun nanofiber scaffolds for use in drug delivery. Hadjiargyrou M; Chiu JB Expert Opin Drug Deliv; 2008 Oct; 5(10):1093-106. PubMed ID: 18817515 [TBL] [Abstract][Full Text] [Related]
18. Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications. Booth BA; Vidal Denham L; Bouhanik S; Jacob JT; Hill JM Drugs Aging; 2007; 24(7):581-602. PubMed ID: 17658909 [TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence and machine learning assisted drug delivery for effective treatment of infectious diseases. He S; Leanse LG; Feng Y Adv Drug Deliv Rev; 2021 Nov; 178():113922. PubMed ID: 34461198 [TBL] [Abstract][Full Text] [Related]
20. Overcoming obstacles to develop effective and safe siRNA therapeutics. Li L; Shen Y Expert Opin Biol Ther; 2009 May; 9(5):609-19. PubMed ID: 19392577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]